China gets tough on advertising regulations
This article was originally published in Clinica
A system to grade companies' compliance with medical advertising regulations will be set up by China's State Food and Drug Administration (SFDA), effective from January 1 2008. However, some companies are fearful that the system may lead to them losing their advertising licences.
You may also be interested in...
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.